C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent

被引:86
|
作者
Trudel, M [1 ]
Lanoix, J [1 ]
Barisoni, L [1 ]
Blouin, MJ [1 ]
Desforges, M [1 ]
LItalien, C [1 ]
DAgati, V [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1997年 / 186卷 / 11期
关键词
D O I
10.1084/jem.186.11.1873
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) induced by the dysregulated expression of c-myc in renal tissue. In situ hybridization analysis demonstrated intense signal for the c-myc transgene overlying tubular cystic epithelium in SBM mice. Renal proliferation index in SBM kidneys was 10-fold increased over nontransgenic controls correlating with the presence of epithelial hyperplasia. The specificity of c-myc for the proliferative potential of epithelial cells was demonstrated by substitution of c-myc with the proto-oncogene c-fos or the transforming growth factor (TGF)-alpha within the same construct. No renal abnormalities were detected in 13 transgenic lines established, indicating that the PKD phenotype is dependent on functions specific to c-myc. We also investigated another well characterized function of c-myc, the regulation of apoptosis through pathways involving p53 and members of the bcl-2 family, which induce and inhibit apoptosis, respectively. The SBM kidney tissues, which overexpress c-myc, displayed a markedly elevated (10-100-fold) apoptotic index. However, no significant difference in bcl-2, bax, or p53 expression was observed in SBM kidney compared with controls. Direct proof that the heightened renal cellular apoptosis in PKD is not occurring through p53 was obtained by successive matings between SBM and p53(-/-) mice. All SBM offspring, irrespective of their p53 genotype, developed PKD with increased renal epithelial apoptotic index. In addition, overexpression of both bcl-2 and c-myc in double transgenic mice (SBB+/SBM+) also produced a similar PKD phenotype with a high apoptotic rate, showing that c-myc can bypass bcl-2 in vivo. Thus, the in vivo c-myc apoptotic pathway in SBM mice occurs through a p53- and bcl-2-independent mechanism. We conclude that the pathogenesis of PKD is c-myc specific and involves a critical imbalance between the opposing processes of cell proliferation and apoptosis.
引用
收藏
页码:1873 / 1884
页数:12
相关论文
共 50 条
  • [1] c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas
    Couillard, M
    Guillaume, R
    Tanji, N
    D'Agati, V
    Trudel, M
    CANCER RESEARCH, 2002, 62 (08) : 2210 - 2214
  • [2] MEDIATION OF C-MYC-INDUCED APOPTOSIS BY P53
    HERMEKING, H
    EICK, D
    SCIENCE, 1994, 265 (5181) : 2091 - 2093
  • [3] c-myc, p53 and bcl-2 in uveal melanoma
    Chana, JS
    Wilson, GD
    Alexander, RA
    Myatt, N
    Neale, M
    Foss, AJE
    Hungerford, JL
    Cree, IA
    JOURNAL OF PATHOLOGY, 1998, 184 : 33A - 33A
  • [4] Bcl-2, p53 and c-myc expression in juvenile dermatomyositis
    Falcini, F
    Calzolari, A
    Generini, S
    Pignone, A
    Simonini, G
    Zulian, F
    Matucci-Cerinic, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) : 643 - 646
  • [5] Function of apoptosis and expression of the proteins Bcl-2,p53 and C-myc in the development of gastric cancer
    An Gao Xu Shao Guang Li Ji Hong Liu Ai Hua Gan Research Laboratory of Digestive Disease
    World Journal of Gastroenterology, 2001, (03) : 403 - 406
  • [6] Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer
    Xu, AG
    Li, SG
    Liu, JH
    Gan, AH
    WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (03) : 403 - 406
  • [7] Resistance of mouse myeloid leukemia cells to apoptosis: involving of c-Myc, Bcl-2 and p53
    Hadzija, MP
    Poljak-Blazi, M
    Hadzija, M
    PERIODICUM BIOLOGORUM, 2002, 104 (04) : 381 - 387
  • [8] Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice
    de la Coste, A
    Mignon, A
    Fabre, M
    Gilbert, E
    Porteu, A
    Van Dyke, T
    Kahn, A
    Perret, C
    CANCER RESEARCH, 1999, 59 (19) : 5017 - 5022
  • [9] Bcl-2, c-myc and p53 immunohistochemical analysis in uveal melanoma
    Blasi, MA
    Rota, R
    Serra, MG
    Calvisi, G
    Balestrazzi, E
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1107 - 1107
  • [10] Bcl-2 and p53: Role in dopamine-induced apoptosis and differentiation
    Porat, S
    Simantov, R
    OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 : 372 - 375